Summary. Insulin resistance is a critical component underlying the altered glucose homeostasis in a variety of metabolic and non-metabolic disorders. Aging, body fat distribution, obesity, diabetes mellitus or hypertension are well recognized conditions associated with an impaired tissue sensitivity to insulin action. Apart from such constant factors, insulin sensitivity can be acutely modified by independent variables such as physical exercise, dietary factors, alcohol intake or harmless drugs. To evaluate the day-to-day intra-individual variation in insulin sensitivity, glucose homeostasis and lipid profiles, we investigated the insulin sensitivity index (SI) (determined by the minimal model method of Bergman), basal and post-glucose-load insulin and glucose levels, serum total triglyceride and lipoprotein cholesterol fractions in 15 healthy young men (24 + 1 year, mean + SEM), on two different occasions at an interval of 3 weeks (days 1 and 21), after 3 days of a standard dietary regimen and after an overnight fast. Blood pressure, heart rate, body weight and 24 h urinary sodium excretion were almost identical in the two phases. S~/~ay 2/varied from 4.2 to 15.8.10 4. min ~ pro gU/ml (mean: 10.2 + 0.9) and correlated with S~day2~ (11.2 + 1.2. 10 -4.min ~pro gU/ml, r = 0.78,p < 0.0007). The slope of the relationship did not differ from 1 (1.01, p > 0.90), the intercept was close to the origin (0.8,p > 0.73) and the coefficient of variation was 14.4%. Other variables of carbohydrate and lipid metabolism that were strongly correlated to each other on the two different days were: total serum lipids (p < 0.0009 to 0.0002) and the fasting and peak plasma insulin (p < 0.001 to 0.0001) and glucose levels (p < 0.005 to 0.001). These findings indicate that the assessment of in vivo insulin sensitivity using the minimal model method is practical and can be reproduced with accetable intra-individual variation in young healthy subjects.
Since the introduction of the first approach to measure insulin sensitivity in vivo by Himsworth in the 1930's [1, 2] , a number of other techniques for the evaluation of insulin sensitivity of the intact organism have emerged. However, the clinical assessment of insulin sensitivity has long been hindered by methodological limitations, and indeed a simple, sensitive and reproducible method for detecting slight endogenous or drug-related changes in insulin sensitivity in vivo is still lacking.
The "gold standard" for physiological studies so far has been the euglycaemic insulin clamp technique developed by Andres and De Fronzo [3] [4] [5] [6] . This technique basically utilizes a constant insulin infusion to increase the glucose disappearance rate and a variable glucose infusion to maintain relatively constant plasma glucose levels [3] [4] [5] [6] . The rate of glucose disposal is then a measure of the sensitivity of tissue to the action of insulin. Another method currently used is the insulin suppression test [6] [7] [8] . This protocol involves the inhibition of endogenous insulin secretion using either epinephrine and propranolol or somatostatin infusions. Exogenous insulin and glucose are infused concomitantly at constant rates, and the steadystate plasma glucose (SSPG) is considered a measure of the response to insulin resistance. A dynamic assessment of insulin sensitivity with mathematical (computer) modelling, termed the minimal model method, was developed by Bergman et al. in 1979 [6, 9-12] . The insulin and glucose data obtained from an intravenous glucose tolerance test can be implemented in a computer program, which is able to estimate a measure of insulin sensitivity. This method has been validated by comparative assessment with the euglycaemic insulin clamp technique [11, 12] .
Regardless of the method used to measure insulin sensitivity, the latter is influenced by independent variables susceptible to daily variations such as the lipoprotein profile [13] , dietary composition [14, 15] , physical activity [16] and drugs such as alcohol [17] , aspirin [18] or nose drops containing adrenergic agonists [19] . Considering these confounding factors, it seems reasonable to argue that any measurement of insulin sensitivity could be liable to wide day-to-day intra-individual variations. So far few data have allowed only an indirect insight in the reproducibility of insulin sensitivity measurements [15, 20] .
Therefore, considering the increasing interest in the pathogenic and therapeutic relevance of insulin resistance, the present study was designed to assess the intraindividual variation in insulin sensitivity index (S 0 as measured with the minimal model method.
Subjects and methods
The study group consisted of 15 young (24 _+ 1 year, mean _+ SEM) normotensive healthy male subjects. None had first degree relatives with diabetes mellitus. The body mass index in all volunteers was less than 25 kg/m 2 (21.9_+ 0.5) and the waist/hip ratio was 0.85-+ 0.02. All subjects were non-diabetic volunteers in excellent physical and mental condition, and with a blood pressure consistently < 140/90 mmHg; none was taking any drugs. Information on the family history of diabetes mellitus in parents and any siblings was obtained from the family doctors, the information was further validated by direct questioning of all parents. Insulin sensitivity and additional variables were assessed on two different days at a 3-week interval (day 1 and 21), using a modified frequent sampling intravenous glucose tolerance test (FSIGT) [21] .
The volunteers consumed a standard diet [14, 15] , containing 2500 kcal with 45% carbohydrates, 40% fat and 15% proteins during the 3 days prior to each study day. The salt intake was also standardized at 160 mmol daily, and 24-h urine specimens were collected to monitor compliance. From one week preceding the first FSIGT procedure and during the entire duration of the study, alcohol ingestion was banned, and the subjects were instructed to maintain their usual physical activity. Caffeine and smoking were avoided for at least 3 days before the tests. The study was approved by the local ethical commitee and the subjects gave their written informed consent prior to the studies.
Procedures
The subjects entered the research unit at 07.00 hours after a 12-h overnight fast. They were asked to empty their bladders for completion of the 24-h urine collection, and body weight was recorded. Thereafter, the subjects assumed and maintained a supine position throughout the entire procedure. S~ was assessed dynamically by the minimal model method [9, 12] with the use of the modified FSIGT [21] . Intravenous cannulas were placed in an antecubital vein of each arm. One was used for glucose and tolbutamide injection; blood was sampled from the needle in the contralateral arm, which was maintained patent with a slow saline infusion (154 mmol/1NaC1, 1.0 ml/min). A fier needle placement, 30 min of rest were allowed for reattainement of basal conditions. Basal samples were taken at -20 and -10 rain; at 08.00 hours (t = 0) the modified FSIGT was begun with an injection of 50% D-glucose (300 mg/kg body weight), administered smoothly over 60 s in an arm vein. At t = 20 rain, 300 mg tolbutamide (Orinase Diagnostic, Upjohn Co., Kalamazoo, Mich., USA) was injected in the same vein. Post-injection samples (3 ml) were collected from the contralateral vein throughout 180 min, according to the modified FSIGT protocol [21] . Sampling tubes contained 10 U powdered heparin as anticoagulant and 2 mg NaF as glycolytic inhibitor; extreme care was taken to avoid contamination of the samples either with each other or with the saline. To achieve this, we used two adjacent stopcocks in the saline infusion.
Blood for determination of serum total lipids, lipoprotein fractions, plasma sodium, potassium and creatinine was collected at t = -20 rain.
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Analytical methods
Insulin determinations from the two tests in one subject were always carried out in the same assay. Radioimmunoassay for measurement of plasma insulin was performed in duplicate, using Guinea pig antiporcine insulin antibody (Novo-BioLabs, B agsvaerd, Denmark) and I12S-porcine insulin as tracer in a working buffer consisting of 12.1 g Tris/HC1 pH 7.4, 0.2 g neomycin sulphate, 0.1 g sodium azide, 1 g EDTA and 0.3% bovine serum albumin. Plasma samples (100 btl) were incubated overnight in a final volume of 600 gl of working buffer containing antibody and tracer. Bound and free ligand were separated using dextran coated charcoal. Standard curves were constructed using canine insulin. Intra-and inter-assay coefficients of variation were 6.5% and 10.1% (n = 30), respectively. Plasma glucose was measured in triplicate with a Technicon AAII autoanalyzer (Tarrytown, NY, USA) by the glucose oxidase technique. Intraassay coefficient of variation was 1.3%. Serum total plasma cholesterol and triglycerides were measured by enzymatic methods (Boehringer-Mannheim, Mannheim, FRG). Lipoproteins were quantitated according to the Lipid Research Clinic recommendations [22] . Very-low-density lipoproteins (VLDL) were separated by ultracentrifugation (Airfuge, Beckman Instruments, Tarrytown, NY, USA). In the infranatant, cholesterol was measured (LDL + HDL) and LDL precipitated by phosphotungstate (Mg 2+) [23] . HDL-cholesterol was then measured in the supernatant. LDLcholesterol was calculated as the difference between these two measurements. The inter-assay coefficients of variation were 4.5% for LDL cholesterol and 3.5% for HDL cholesterol (n = 10).
Data analysis and statistics
The S I was calculated from FSIGT results using the program MIN-MOD (copyright R.N. ). This program accepts as input the temporal pattern of plasma insulin during the modified FSIGT, and it must fit a simple (minimal) model of insulin-dependent glucose utilization to the measured glucose pattern. The model is the simplest mathematical representation that can account for the glucose dynamics during the modified FSIGT. The equations of the model are as follows [9] : dG(t)/dt=-[pl+X(t)]-G(t)+p~.Gb, dX(t)/dt =-pz.X(t)+p3.I(t), where G(t) and I(t) are the plasma glucose and insulin concentrations. X(t) represents the time-dependent effect of the dynamic insulin response to accelerate glucose decline during the modified FSIGT. Gb is the pre-injection glucose concentration. Parameters of the model are estimated from the least-squares fitting of the glucose data, and S~ is calculated as the ratio of two of the fitted model parameters. This parameter is a measure of the effect of an increment in plasma insulin to enhance the fractional net disappearance of glucose from the extracellular compartment of glucose distribution.
Statistical analysis
Statistical analysis was performed with the help of the Statistical Analysis System software package (version 6.03, SAS Institute, Inc., Cary, NC, USA). Paired t-test was applied for comparison between two related samples throughout the study, and Pearson correlation analysis was used for assessment of relationships between variables.
Results
In these lean, normotensive and normolipidaemic male subjects, blood pressure (130/76 +3/2 vs 125/76_+ 3/3mmHg, day l vs day21), heart rate (62+2 vs 59 + 4 beats per min), body weight (69 + 2 vs 69 + 2 kg), plasma creatinine (99_+2 vs 95_+3Bmol/1), sodium Compared with day 1, serum total triglycerides, total cholesterol, HDL-cholesterol and LDL-cholesterol were unchanged after the 21 days of observation ( Table 1) . Coefficients of correlations between values obtained on days i and 21, respectively ranged from r = 0.73 for HDLcholesterol (p < 0.002) to r = 0.83 for total triglycerides (p < 0.0002). 529 drates [24] . Using the minimal model method, insulin sensitivity determined in eight healthy subjects on a normal and after 3 to 5 days of a very high carbohydrate intake (41 and 85% of total calories, respectively) was found to differ by 8.2% only [15] . However, none of these studies provided information on coefficients of variation and correlations between repeated determinations.
Apart from the well-known categorical variables, insulin sensitivity may be acutely impaired by several independent continuous variables which are liable to daily variations [13] [14] [15] [16] [17] [18] [19] . In the present study, metabolic testing was performed on a standard diet, and intake of alcohol or drugs was avoided. Pharmacological interactions are potentially important, since Shelmet an co-workers reported a 35% reduction in glucose disposal upon infusion of ethanol causing a steady-state blood alcohol level of 0.6 g/1 [17] ; while administration of aspirin at a daily dosage of 3 g for 3 days decreased insulin sensitivity by about 28% [18] . Additional modifying factors, such as serum lipoprotein composition [13] or physical activity [16, 25, 26] , were stable on the two study days.
Normal human subjects display a wide range of insulin sensitivity. This could not be explained by differences in age, weight, body fat distribution (waist-hip ratio) or blood pressure [8, 15, [27] [28] [29] , as their inter-individual variability in the present study group was minimal. Insulin mediated glucose disposal depends on complex receptor and post-receptor interactions [30, 31] as well as on tissue blood flow [32] . Moreover, physical activity may have an important influence, modifying insulin sensitivity over weeks rather than acutely [16, 25, 26] . In 10 middle-aged men, a weekly effort of 30 to 40 rain of jogging over 9 weeks produced a 26% improvement in insulin sensitivity [16] .
Furthermore, methodological aspects deserve consideration, includhag the acute stress reaction and room temperature during the investigative procedure. The influence of these factors is difficult to quantitate. Our subjects were studied in the same room at approximately
Discussion
These findings indicate that the assessment of insulin sensitivity in vivo using the minimal model method is practical and can be reproduced with only small intra-individual variations. In the 15 young men studied, the difference in S~ averaged 8.9%, and the mean coefficient of intra-individual variation was 14.4%. Moreover, S~ values at the two time points correlated closely (r = 0.78, p < 0.0007), the slope of this relationship was not significantly different from 1.00, and the intercept did not differ fi'om 0.
Utilising the euglycaemic insulin clamp technique, Pollate et al. reported in a group of 50 hypertensive patients a 17% difference between the mean insulin-sensitivity indices determined on two different occasions during placebo administration [20] . With application of the insulin suppression test, an 8.9% difference between the mean steady-state plasma glucose levels, assessed on two different occasions 10 days apart, was described in 19 nonobese subjects ingesting a diet containing 43% carbohy- the same temperature, while psycological stress would be expected to be greater during the first than the second procedure. Finally, a certain degree of measurement error is to be expected. Considering the intra-and inter-assay variations of plasma glucose and insulin assays, an estimation of the measurement error would yield a coefficient of variation in insulin sensitivity by the minimal model of approximately 8 to 10%.
In conclusion, these data show that minimal model analysis of FSIGT procedures yields a measure of insulin sensitivity which is reproducible with moderate intra-individual variations when manageable confounding factors are controlled. The FSIGT is also relatively easy to perform and, therefore, potentially useful for the evaluation and monitoring of insulin sensitivity in non-diabetic individuals.
